---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-21-034304"
form_type: "8-K"
ticker: "TPB"
cik: "0001290677"
company_name: "Turning Point Brands, Inc."
filed_at: "2021-10-12T23:59:59+00:00"
generated_at: "2026-06-28T21:20:10.775431+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# FDA rescinds Marketing Denial Order on TPB vapor products; products remain under review

## Summary
- On Oct 7, FDA rescinded its Sept 14 Marketing Denial Order for certain TPB vapor products, citing need for further review.
- All proprietary vapor products (incl. Solace e-liquids) will continue marketing while PMTAs remain under FDA review.
- TPB withdrew its petition for review and motion to stay filed with the 6th Circuit following the rescission.
- CEO Larry Wexler expressed encouragement and reiterated commitment to evidence-based PMTA process.

## SEC filing metadata
- accession: 0001140361-21-034304
- form_type: 8-K
- ticker: TPB
- cik: 0001290677
- company_name: Turning Point Brands, Inc.
- filed_at: 2021-10-12T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1290677/000114036121034304/0001140361-21-034304-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1290677/000114036121034304/brhc10029756_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-21-034304
- JSON: https://secwatch.observer/filing/0001140361-21-034304.json
- Plain text: https://secwatch.observer/filing/0001140361-21-034304.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.